<DOC>
	<DOCNO>NCT02504580</DOCNO>
	<brief_summary>A Phase 2 , Randomized , Pilot Study Investigate Safety , Efficacy , Pharmacokinetics Bioavailability HTX-011 , HTX-002 , HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy</brief_summary>
	<brief_title>A Pilot Study Investigate Safety , Efficacy , Pharmacokinetics Bioavailability HTX-011 , HTX-002 , HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy</brief_title>
	<detailed_description />
	<mesh_term>Hernia , Inguinal</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Be male female 18 year age old . 2 . Female subject eligible follow apply : Not pregnant ( female subject child bear potential must negative serum pregnancy test screen negative urine pregnancy test surgery ) Not lactate Not plan become pregnant study Be surgically sterile ; least two year postmenopausal ; monogamous partner surgically sterile ; practice doublebarrier contraception ; practice abstinence ( must agree use doublebarrier contraception event sexual activity ) ; use insertable , injectable , transdermal , combination oral contraceptive approve FDA great 2 month prior screen visit commits use acceptable form birth control duration study 30 day completion study Male : Must surgically sterile ( biologically surgically ) commit use reliable method birth control duration study least 1 week administration study medication . 3 . Plan undergo unilateral inguinal herniorrhaphy 4 . Have ability willing comply study procedures 5 . Must able understand study procedure give inform consent conduct study procedure , use IRB approve consent form . 1 . Unwilling sign inform consent willing able complete study procedure 2 . Have contraindication allergic medication use trial period 3 . Have clinically significant cardiac abnormality , opinion investigator would pose health risk subject participate trial 4 . Have American Society Anesthesiologists ( ASA ) Physical Status classification system category 4 great ( Appendix E ) 5 . Have clinically significant renal hepatic abnormality ( define AST ALT &gt; 3x ULN , creatinine &gt; 2x ULN ) 6 . Have another painful condition may confound pain assessment 7 . Have another surgery plan within 30 day procedure , present bilateral recurrent inguinal hernia , hernia presentation , hernias large scrotal component would difficult reduce surgically 8 . Have know suspected history alcohol drug abuse , positive drug screen 9 . Currently take analgesic chronically painful condition , take long acting opioids within 3 day surgery , take opioids within 24 hour surgery 10 . Subjects document sleep apnea home continuous positive airway pressure ( CPAP ) 11 . Female subject pregnant ( positive pregnancy test screen day surgery ) 12 . Subjects receive oxygen therapy time screen 13 . Have participate clinical trial within 30 day plan surgery 14 . Have body mass index ( BMI ) &gt; 39 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>